Abingdon Health Plc (ABDX) is a Medical diagnostics research company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Abingdon Health Plc in 2026. The next earnings report is expected on November 18, 2026.
Next earnings date
18 Nov 2026
In 90 days
EPS estimate
0.00
Revenue estimate
10.5M
Past earnings
No dividend history available.
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Abingdon Health Plc (ABDX) is scheduled to report earnings on November 18, 2026.
Abingdon Health Plc (ABDX) last reported earnings on March 17, 2026.
Abingdon Health Plc (ABDX) is listed on London Exchange.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.